Literature DB >> 2173351

Biochemical characterization and autoradiographic localization of [3H]PGE2 binding sites in rat kidney.

L O Eriksson1, B Larsson, K E Andersson.   

Abstract

Specific binding sites for prostaglandin E2 (PGE2) in membranes obtained from whole kidney and from different areas of rat renal tissue were identified and quantified by in-vitro radioligand binding and localized by autoradiography. Analysis of the [3H]PGE2 binding by Scatchard plots revealed a single class of high-affinity binding sites in the whole kidney (KD = 5.1 +/- 0.4 nM; Bmax = 75 +/- 9 fmol mg-1 protein), the cortex (KD = 6.1 +/- 0.5 nM; Bmax = 58 +/- 5 fmol mg-1 protein) and the outer medulla (KD = 3.3 +/- 0.3 nM; Bmax = 376 +/- 59 fmol mg-1 protein). No reproducible Scatchard plots could be obtained in the inner medulla. PGE1 was equipotent with PGE2 in inhibiting [3H]PGE2 binding, whereas PGA2, PGB2, PGF2 alpha and PGI2 were 10- to 1000-fold less potent. Autoradiographs revealed sparse or no binding in glomeruli, proximal tubules or blood vessels. The pattern of distribution of [3H]PGE2 binding was consistent with the anatomical localization of the distal tubule and in particular the thick ascending limbs of Henle. Based on the distribution and cellular localization of the [3H]PGE2 binding sites, our data support the hypothesis that the physiological role of PGE2 receptors is coupled to the regulation of sodium transport across segments of the distal tubule.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2173351     DOI: 10.1111/j.1748-1716.1990.tb08941.x

Source DB:  PubMed          Journal:  Acta Physiol Scand        ISSN: 0001-6772


  2 in total

1.  Endogenously produced prostanoids stimulate calcium reabsorption in the rabbit cortical collecting system.

Authors:  J van Baal; M D de Jong; F J Zijlstra; P H Willems; R J Bindels
Journal:  J Physiol       Date:  1996-11-15       Impact factor: 5.182

2.  The EP2 receptor is the predominant prostanoid receptor in the human ciliary muscle.

Authors:  T Matsuo; M S Cynader
Journal:  Br J Ophthalmol       Date:  1993-02       Impact factor: 4.638

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.